Abiomed says it's renewing a licensing deal with Opsens for fiber-optic pressure sensor technology to integrate into its Impella line of heart pumps.
Abiomed (NSDQ:ABMD) said it renewed a licensing deal with Opsens (TSX:OPS.V) to integrate that company's fiber-optic pressure sensor technology into Abiomed's Impella line of heart pumps.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1iUFwAq
Cap comentari:
Publica un comentari a l'entrada